scispace - formally typeset
C

Claudio P. Albuquerque

Researcher at Ludwig Institute for Cancer Research

Publications -  26
Citations -  2806

Claudio P. Albuquerque is an academic researcher from Ludwig Institute for Cancer Research. The author has contributed to research in topics: Phosphorylation & SUMO protein. The author has an hindex of 18, co-authored 26 publications receiving 2456 citations. Previous affiliations of Claudio P. Albuquerque include University of California, San Diego.

Papers
More filters
Journal ArticleDOI

A Multidimensional Chromatography Technology for In-depth Phosphoproteome Analysis

TL;DR: A multidimensional chromatography technology, combining IMAC, hydrophilic interaction chromatography, and reverse phase LC, for phosphopeptide purification and fractionation is developed, suited for in-depth phosphoproteome studies.
Journal ArticleDOI

Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases.

TL;DR: Qualitative phosphoproteomics was used to identify in vivo kinase substrates of the yeast DNA damage checkpoint kinases Mec1, Tel1, and Rad53 (orthologs of human ATR, ATM, and CHK2, respectively), suggesting that a wide range of cellular processes is likely regulated by these kinases.
Journal ArticleDOI

ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS

TL;DR: In this paper, Tandem-affinity purification and quantitative mass spectrometry were used to identify TDP-43 complexes not only with heterogeneous nuclear ribonucleoproteins family proteins, as expected, but also with components of Drosha microprocessor complexes, consistent with roles for TDP43 in both mRNA processing and microRNA biogenesis.
Journal ArticleDOI

ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP.

TL;DR: These studies establish potentially converging disease mechanisms in ALS and spinal muscular atrophy, with ALS-causative mutants acquiring properties representing both gain and loss of function, including reduced RNA processing mediated by U1-snRNP.